BOZZATO, DANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.437
AS - Asia 5.675
EU - Europa 2.212
SA - Sud America 823
AF - Africa 707
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 47
AN - Antartide 1
Totale 17.966
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.978
SG - Singapore 1.886
CN - Cina 1.132
VN - Vietnam 1.008
BR - Brasile 548
HK - Hong Kong 519
IT - Italia 276
PL - Polonia 234
FI - Finlandia 224
FR - Francia 197
SE - Svezia 183
DE - Germania 165
IN - India 154
GB - Regno Unito 122
RU - Federazione Russa 105
NL - Olanda 96
BD - Bangladesh 87
CA - Canada 80
IQ - Iraq 68
UA - Ucraina 67
MX - Messico 63
JP - Giappone 61
SA - Arabia Saudita 60
TR - Turchia 60
ID - Indonesia 54
PK - Pakistan 54
AR - Argentina 52
ZA - Sudafrica 51
ES - Italia 49
PH - Filippine 43
EC - Ecuador 35
EG - Egitto 35
CO - Colombia 34
KR - Corea 34
BJ - Benin 31
NP - Nepal 29
TN - Tunisia 29
AT - Austria 28
BW - Botswana 28
IE - Irlanda 28
VE - Venezuela 28
DK - Danimarca 27
LB - Libano 27
PY - Paraguay 27
RO - Romania 27
HR - Croazia 26
KE - Kenya 26
UG - Uganda 26
UZ - Uzbekistan 26
CL - Cile 24
LY - Libia 24
AZ - Azerbaigian 23
GT - Guatemala 23
PA - Panama 23
PE - Perù 23
PR - Porto Rico 23
PT - Portogallo 23
AO - Angola 22
BG - Bulgaria 22
CR - Costa Rica 22
DO - Repubblica Dominicana 22
KZ - Kazakistan 22
MD - Moldavia 22
AU - Australia 21
CW - ???statistics.table.value.countryCode.CW??? 21
DZ - Algeria 21
ET - Etiopia 21
GF - Guiana Francese 21
GR - Grecia 21
JM - Giamaica 21
LC - Santa Lucia 21
MA - Marocco 21
MY - Malesia 21
TJ - Tagikistan 21
BZ - Belize 20
CY - Cipro 20
JO - Giordania 20
KH - Cambogia 20
TH - Thailandia 20
AE - Emirati Arabi Uniti 19
AL - Albania 19
BA - Bosnia-Erzegovina 19
CV - Capo Verde 19
PS - Palestinian Territory 19
TW - Taiwan 19
TZ - Tanzania 19
BB - Barbados 18
BO - Bolivia 18
BY - Bielorussia 18
CI - Costa d'Avorio 18
EE - Estonia 18
GN - Guinea 17
IL - Israele 17
ME - Montenegro 17
MZ - Mozambico 17
NE - Niger 17
SN - Senegal 17
SO - Somalia 17
CZ - Repubblica Ceca 16
EU - Europa 16
Totale 17.250
Salva come PNG Salva come JPEG
Città #
Singapore 1.203
Ashburn 1.058
San Jose 923
Woodbridge 621
Chandler 553
Ann Arbor 550
Fairfield 543
Houston 514
Hong Kong 444
Ho Chi Minh City 300
Hanoi 227
Cambridge 217
Wilmington 215
Beijing 212
Seattle 194
Bytom 185
Los Angeles 168
Jacksonville 160
Santa Clara 158
Boardman 155
Des Moines 118
Princeton 114
Helsinki 107
Medford 103
Lauterbourg 98
New York 86
Dong Ket 79
Nanjing 76
São Paulo 66
Roxbury 57
Da Nang 56
San Diego 54
Padova 53
Buffalo 48
Guangzhou 44
Haiphong 38
Tokyo 37
Orem 35
Redondo Beach 34
Cotonou 31
Jinan 31
Warsaw 31
Munich 30
Baghdad 29
Frankfurt am Main 29
Tianjin 29
Chicago 28
Shenyang 28
Montreal 27
Shanghai 27
Kampala 26
Changsha 24
Dallas 24
London 24
Hebei 23
Nairobi 23
Tashkent 23
Johannesburg 22
Nanchang 22
Phoenix 22
Riyadh 22
Dublin 21
Panama City 21
Amsterdam 20
Baku 20
Cairo 20
Castries 20
Gaborone 20
Jeddah 20
Luanda 20
Milan 20
Phnom Penh 20
Chennai 19
Dushanbe 19
Hải Dương 19
San Francisco 19
Toronto 19
Biên Hòa 18
Lima 18
New Delhi 18
Zhengzhou 18
Amman 17
Atlanta 17
Dakar 17
Guatemala City 17
Praia 17
Stockholm 17
Abidjan 16
Addis Ababa 16
Bridgetown 16
Brooklyn 16
Conakry 16
Copenhagen 16
Dar es Salaam 16
Istanbul 16
Jiaxing 16
Lusaka 16
Managua 16
San José 16
Tripoli 16
Totale 11.177
Salva come PNG Salva come JPEG
Nome #
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 334
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 328
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 326
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 322
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 295
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 295
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 283
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 264
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 256
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 255
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 245
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 240
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 236
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 235
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 235
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 234
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 229
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 220
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 215
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 215
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 209
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 209
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 206
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 199
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 199
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 194
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 194
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 192
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 187
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 186
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 185
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 184
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 181
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 180
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 180
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 180
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 171
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 169
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 169
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 169
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 167
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 166
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 166
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 166
Genome-wide association study identifies an early onset pancreatic cancer risk locus 166
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 165
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 164
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 164
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 163
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 162
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 160
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 159
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 159
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 158
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 157
The CagL GLU59 Polymorphism of H. pylori is associated with an increasedrisk of gastric cancer. Preliminaryresults from an Italian multicenter study. 156
NT-S100A8 effects on cell signalling. 153
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 153
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 152
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 152
Polimorfismi dei geni KLK3, RASA1 e NAALADL2: rischio di cancro alla prostata, aggressività della neoplasia e livelli sierici dell’Antigene Prostatico-Specifico 148
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 145
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 145
Erythrocyte sedimentation rate and c-reactive protein in acute inflammation: Meta-analysis of diagnostic accuracy studies 144
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 143
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 143
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 142
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 141
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 140
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 138
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 137
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 137
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 137
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 133
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 133
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 132
Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. 131
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 129
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 128
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 128
Genome-wide association study identifies an early onset pancreatic cancer risk locus. 127
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 126
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 125
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 125
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 123
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 119
The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells 119
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 118
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 116
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 115
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 115
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 114
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 112
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 112
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 108
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 108
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 105
Quality indicators to monitor the rejected outpatients' samples 103
Discovery of New Serum Biomarkers for Pancreatic Cancer Diagnosis by MALDI-TOF Analysis. 103
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 102
Totale 17.262
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.449
article - articoli 20.914
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 0 0 0 0 0 104 171
2021/2022952 14 182 48 49 43 98 31 75 49 13 65 285
2022/20231.164 206 127 13 131 197 169 4 76 158 9 44 30
2023/2024592 23 70 70 49 46 63 53 65 18 36 40 59
2024/20252.522 14 128 133 121 320 54 118 199 220 96 486 633
2025/20269.074 428 766 1.135 993 1.025 376 1.613 887 1.023 568 260 0
Totale 18.039